| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/15/2004 | WO2004005531A2 Targeting and tracking of cells to specific organs and tissues in vivo |
| 01/15/2004 | WO2004005530A2 Compositions and methods for treatment and detection of multiple cancers |
| 01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/15/2004 | WO2004005512A1 Nove protein and use thereof |
| 01/15/2004 | WO2004005510A1 NOVEL Nogo RECEPTOR-LIKE POLYPEPTIDE AND DNA THEREOF |
| 01/15/2004 | WO2004005497A1 Method of screening insulin resistance improving drug |
| 01/15/2004 | WO2004005495A1 Novel airway epithelial cell line and use thereof |
| 01/15/2004 | WO2004005486A2 Mp21s as modifiers of the p21 pathway and methods of use |
| 01/15/2004 | WO2004005483A2 ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 01/15/2004 | WO2004005481A2 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | WO2004005479A2 A high resolution typing system for pathogenic borrelia |
| 01/15/2004 | WO2004005477A2 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 01/15/2004 | WO2004005476A2 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | WO2004005474A2 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | WO2004005470A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 01/15/2004 | WO2004005469A2 Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers |
| 01/15/2004 | WO2004005466A2 Methods and compositions for diagnosing hepatocellular carcinoma |
| 01/15/2004 | WO2004005465A2 Compositions and methods for the detection of human t cell receptor variable family gene expression |
| 01/15/2004 | WO2004005457A2 Tfc/ beta-catenin regulated genes for treating cancer |
| 01/15/2004 | WO2004005451A2 Method for detecting the von willebrand factor-cleaving protease activity of adamts-13 |
| 01/15/2004 | WO2004005337A1 Phosphoinositolglycan (pig)-binding protein from adipocytes |
| 01/15/2004 | WO2004005333A1 Use of hepatitis c virus (hcv) p7 protein |
| 01/15/2004 | WO2004005323A2 Affinity small molecules for the epo receptor |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2004005320A2 ErbB-2 RECEPTOR TARGETING PEPTIDE |
| 01/15/2004 | WO2004005319A2 Microarrays on mirrored substrates for performing proteomic analyses |
| 01/15/2004 | WO2004005316A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 01/15/2004 | WO2004005286A2 Viral inhibitors |
| 01/15/2004 | WO2004004998A1 A process and apparatus for the vulcanization |
| 01/15/2004 | WO2004004817A1 Method and apparatus for the administration of co |
| 01/15/2004 | WO2004004771A1 Immunopotentiating compositions |
| 01/15/2004 | WO2004004766A1 MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 01/15/2004 | WO2004004760A1 Vaccine for feline infectious peritonitis |
| 01/15/2004 | WO2004004707A1 Polymer affinity matrix, a method for the production and use thereof |
| 01/15/2004 | WO2004004698A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | WO2004004668A2 Immune modulatory activity of human ribonucleases |
| 01/15/2004 | WO2004004666A2 Modulators of leukocyte activation, hck compositions and methods of use |
| 01/15/2004 | WO2004004662A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2004 | WO2004004652A2 Mitotic kinesin binding site |
| 01/15/2004 | WO2004004649A2 Compositions and methods for the treatment of immune related diseases |
| 01/15/2004 | WO2004004647A2 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
| 01/15/2004 | WO2004004643A2 Interferon gamma in the detection and treatment of angiomyolipomas |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2003100088A3 Method and kit for measuring mitochondrial activity in human lymphocytes |
| 01/15/2004 | WO2003099868A3 Method for obtaining anti-idiotype antibodies |
| 01/15/2004 | WO2003096009A3 Fluid tester |
| 01/15/2004 | WO2003082216A3 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/15/2004 | WO2003079884A3 Methods for diagnosis and prognosis of cancer |
| 01/15/2004 | WO2003078551A3 Oil composition and method of detecting a marker in an oil composition |
| 01/15/2004 | WO2003078456A3 Human diabetes-mediating proteins |
| 01/15/2004 | WO2003077943A3 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound |
| 01/15/2004 | WO2003076589A3 Analysis of apoptotic bodies in bodily fluids |
| 01/15/2004 | WO2003072126A3 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 01/15/2004 | WO2003070195A3 Biglycan and related therapeutics and methods of use |
| 01/15/2004 | WO2003066876A3 An apparatus and methods for using biological material to discriminate an agent |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | WO2003062450A3 Probe correction for gene expression level detection |
| 01/15/2004 | WO2003060499A3 Measuring and sensor assembly for determining a characteristic of a fluid and method for operating the same |
| 01/15/2004 | WO2003060130A3 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/15/2004 | WO2003057170A8 Oral insulin therapy |
| 01/15/2004 | WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors |
| 01/15/2004 | WO2003052130A3 A method for determining the biological activity of defibrotide |
| 01/15/2004 | WO2003052066A3 Klcs as modifiers of the p53 pathway and methods of use |
| 01/15/2004 | WO2003048731A3 Antibody categorization based on binding characteristics |
| 01/15/2004 | WO2003047739A3 Method for producing chemical libraries enhanced with biologically active molecules |
| 01/15/2004 | WO2003046557A3 Hp biopolymer markers predictive of insulin resistance |
| 01/15/2004 | WO2003046548A3 System and technique for detecting foreign material in meat |
| 01/15/2004 | WO2003042660A3 Screening method for predicting susceptibility to breast cancer |
| 01/15/2004 | WO2003040169A3 Human monoclonal antibodies to dendritic cells |
| 01/15/2004 | WO2003036259A3 Assay for phospholipid transfer protein (pltp) activity |
| 01/15/2004 | WO2003033731A3 Methods for detecting ovarian cancer |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2003019183A9 Process for the informative and iterative design of a gene-family screening library |
| 01/15/2004 | WO2003019146A3 High throughput screening assays using fatty acid synthetic enzymes |
| 01/15/2004 | WO2003014383A3 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 01/15/2004 | WO2002097420A8 Protonic conductive membrane gas sensor |
| 01/15/2004 | WO2002092854A3 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 01/15/2004 | WO2002086093A3 Methods of using a hyaluronan receptor |
| 01/15/2004 | WO2002080888A3 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | WO2002078512A3 Blood glucose tracking apparatus and methods |
| 01/15/2004 | WO2002070747A9 Method of molecular diagnosis of chronic myelogenous leukemia |
| 01/15/2004 | WO2002070736A8 Method for the detection of nucleic acid molecules |
| 01/15/2004 | WO2002065119A9 A method for the prediction of molecular interaction networks |
| 01/15/2004 | WO2002046470A3 Testing endosymbiont cellular organelles and compounds identifiable therewith |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | WO2002016940A3 Genomics-assisted rapid identification of targets |
| 01/15/2004 | US20040010813 Comprises nucleotide sequences capable of heart specific transcription for treating cardiomyopathies and cardiovascular disorders; anticardiopathic agents; drug screening |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010525 Method and apparatus for molecular mechanics analysis of molecular systems |
| 01/15/2004 | US20040010515 System and method for data analysis, manipulation, and visualization |
| 01/15/2004 | US20040010381 Self-similar ordered microstructural arrays of amphiphilic molecules |
| 01/15/2004 | US20040010169 Comprising adding to refined liquid petroleum hydrocarbons by adding a (benzo)pyrazinoporphyrazine dye having an absorption maximum from 700 nm to 900 nm. for subsequent identification by electromagnetic waves; lubricating oil, hydraulic fluids |
| 01/15/2004 | US20040010131 Gramnegative bacterial nucleotide sequences for diagnosing infection and generating disease resistant plants |
| 01/15/2004 | US20040010126 Protein mapping |
| 01/15/2004 | US20040010068 Analyzing dielectric or impedance curve; monitoring, controlling vulcanization |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009922 A PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof |
| 01/15/2004 | US20040009911 Hepsin substrates and prodrugs |